Ruili Medical Aesthetic (02135) Fa Yingxi expects profit attributable to shareholders in the medium term to turn a year-on-year loss into a profit of about 4 million yuan

Zhitongcaijing · 1d ago

According to Zhitong Finance App News, Ruili Medical & Aesthetic (02135) announced that the Group expects to record revenue of approximately RMB 115 million for the six months ending June 30, 2026, and approximately RMB 85 million for the six months ending June 30, 2025; and the Group expects to record a profit attributable to shareholders of the parent company of approximately RMB 4 million for the six months ending June 30, 2025, while the six months ended June 30, 2025 recorded losses attributable to shareholders of the parent company.

The Board of Directors believes that the expected change in earnings for the six months ended June 30, 2026 is mainly due to an increase in gross profit of about RMB 15 million due to the Group's revenue growth during the period. This increase is mainly driven by (i) the increase in revenue from medical and aesthetic services; and (ii) the increase in sales of medical aesthetic device products.